Documentdetail
ID kaart

oai:pubmedcentral.nih.gov:1100...

Onderwerp
Case Report
Auteur
Klein, Benjamin Treudler, Regina
Langue
en
Editor

Dustri-Verlag Dr. Karl Feistle

Categorie

Allergologie Select

Jaar

2024

vermelding datum

10-06-2024

Trefwoorden
eosinophilic dupilumab
Metriek

Beschrijving

Abstract.

Background: Eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus that belongs to the spectrum of Th2-mediated diseases.

It is often associated with atopic comorbidities such as allergic asthma (AA) and poses a therapeutic challenge.

Case report: We report on a 43-year-old patient with EoE and AA who did not show sufficient therapeutic control despite standard therapy.

We started treatment with dupilumab, whereupon both EoE and AA rapidly improved and complete symptom resolution could be documented.

The response to dupilumab was assessed by laboratory monitoring and gastroscopy, which showed a reduction of markers of type II inflammation and eosinophilic infiltrates in the esophagus.

Summary: Our report emphasizes the effective and safe use of dupilumab as a treatment option for EoE with concomitant beneficial effects on AA.

Klein, Benjamin,Treudler, Regina, 2024, Rapid response to dupilumab in an adult patient with eosinophilic esophagitis and allergic asthma, Dustri-Verlag Dr. Karl Feistle

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw